Scientists test seven new drug cocktails for tough bladder cancers

NCT ID NCT02546661

Summary

This study is testing the safety and initial effectiveness of several new drug combinations for people with advanced bladder cancer that has continued to grow despite prior treatment. It enrolled 117 participants and assigns them to one of seven different treatment groups based on the specific genetic changes found in their tumor. The main goal is to find safe doses and see if these personalized combinations can help control the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE BLADDER CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Research Site

    Los Angeles, California, 90095, United States

  • Research Site

    New Haven, Connecticut, 06510, United States

  • Research Site

    Fort Myers, Florida, 33901, United States

  • Research Site

    New York, New York, 10029, United States

  • Research Site

    New York, New York, 10032, United States

  • Research Site

    New York, New York, 10116, United States

  • Research Site

    Cleveland, Ohio, 44195, United States

  • Research Site

    Nashville, Tennessee, 37203, United States

  • Research Site

    Edmonton, Alberta, T6G 1Z2, Canada

  • Research Site

    Vancouver, British Columbia, V5Z 4E6, Canada

  • Research Site

    Toronto, Ontario, M5G 2M9, Canada

  • Research Site

    Montreal, Quebec, H3T 1E2, Canada

  • Research Site

    Bordeaux, 33075, France

  • Research Site

    Caen, 14000, France

  • Research Site

    Lyon, 69373, France

  • Research Site

    Marseille, 13273, France

  • Research Site

    Saint-Herblain, 44805, France

  • Research Site

    Toulouse, 31100, France

  • Research Site

    Badalona, 08003, Spain

  • Research Site

    Barcelona, 08035, Spain

  • Research Site

    Barcelona, 08041, Spain

  • Research Site

    Madrid, 28040, Spain

  • Research Site

    Glasgow, G12 0YN, United Kingdom

  • Research Site

    London, EC1M 6BQ, United Kingdom

  • Research Site

    London, W1G 6AD, United Kingdom

  • Research Site

    Manchester, M20 4BX, United Kingdom

  • Research Site

    Southampton, SO16 6YD, United Kingdom

Conditions

Explore the condition pages connected to this study.